An Outpatient, Ambulant-Design, Controlled Human Infection Model Using Escalating Doses of Salmonella Typhi Challenge Delivered in Sodium Bicarbonate Solution
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Typhoid fever is a major global health problem, the control of which is hindered by lack of a suitable animal model in which to study Salmonella Typhi infection. Until 1974, a human challenge model advanced understanding of typhoid and was used in vaccine development. We set out to establish a new human challenge model and ascertain the S. Typhi (Quailes strain) inoculum required for an attack rate of 60%-75% in typhoid-naive volunteers when ingested with sodium bicarbonate solution. METHODS: Groups of healthy consenting adults ingested escalating dose levels of S. Typhi and were closely monitored in an outpatient setting for 2 weeks. Antibiotic treatment was initiated if typhoid diagnosis occurred (temperature ≥38°C sustained ≥12 hours or bacteremia) or at day 14 in those remaining untreated. RESULTS: Two dose levels (10(3) or 10(4) colony-forming units) were required to achieve the primary objective, resulting in attack rates of 55% (11/20) or 65% (13/20), respectively. Challenge was well tolerated; 4 of 40 participants fulfilled prespecified criteria for severe infection. Most diagnoses (87.5%) were confirmed by blood culture, and asymptomatic bacteremia and stool shedding of S. Typhi was also observed. Participants who developed typhoid infection demonstrated serological responses to flagellin and lipopolysaccharide antigens by day 14; however, no anti-Vi antibody responses were detected. CONCLUSIONS: Human challenge with a small inoculum of virulent S. Typhi administered in bicarbonate solution can be performed safely using an ambulant-model design to advance understanding of host-pathogen interactions and immunity. This model should expedite development of diagnostics, vaccines, and therapeutics for typhoid control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3. Kaplan-Meier plots demonstrating time to diagnostic endpoints including all diagnoses (A), those diagnosed using clinical (B) and microbiological (C) criteria, and time to fever (first temperature ≥38°C; [D]) and to first positive blood culture (E), following challenge at 2 dose levels (103 or 104 colony-forming units [CFU]) of Salmonella Typhi (Quailes strain). Shaded gray area, end of 2-week observation period (all remaining participants started on antibiotic therapy); dotted gray line with circle symbols, participants challenged with 103 CFU; dashed black lines with square symbols, participants challenged with 104 CFU.](https://figures.cochat.ai/paper-figures/c29bee3626744f5dbd22d644a7ed99cc/an-outpatient-ambulant-design-controlled-human-infection-model-using-escalating-figure-3.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An experimental human S. Typhi challenge model was recently reestablished, presenting a unique opportunity to investigate typhoid pathogenesis in a controlled setting in the natural host [5–7].”
From Rapidly Escalating Hepcidin and Associated Serum Iron Starvation Are Features of the Acute Response to Typhoid Infection in Humans (2015) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
The diagnostic odds ratio: a single indicator of test performance
Glas, A. S., Lijmer, J. G., Prins, M. H., Bonsel, G. J., & Bossuyt, P. M. M. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(03)00177-x · Cited by 2,261 · cited 1×
“positivity in infection relative to the odds of positivity in the noninfected; 1 indicating that the test does not discriminate between infected and uninfected) [19] and 95% CIs were calculated to assess performance of individual symptoms reported for typhoid diagnosis to be made.”
BackgroundParry, C. M., Hien, T. T., Dougan, G., White, N. J., & Farrar, J. J. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020201 · Cited by 1,112
Self-citationTyphoid fever: pathogenesis and immunologic control
Hornick, R. B., Greisman, S. E., Woodward, T. E., DuPont, H. L., Dawkins, A. T., & Snyder, M. J. (1970) · New England Journal of Medicine · doi:10.1056/nejm197009242831306 · Cited by 565
Acid resistance in enteric bacteria
Gorden, J., & Small, P. L. (1993) · Infection and Immunity · doi:10.1128/iai.61.1.364-367.1993 · Cited by 444 · cited 1×
“For others, such as Shigella dysenteriae or enterotoxigenic Escherichia coli, administration with sodium bicarbonate buffer both reduces the inoculum dose required and results in a more consistent pattern of clinical infection [21–24].”
BackgroundWain, J., Diep, T. S., Ho, V. A., Walsh, A. M., Hoa, N. T. T., Parry, C. M., & White, N. J. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.6.1683-1687.1998 · Cited by 291 · cited 1×
“We found very low numbers of bacteria to be present in the peripheral blood at the time of clinical diagnosis, a finding supported by field data, albeit in an endemic setting [37].”
BackgroundPathogenesis of Shigella dysenteriae 1 (Shiga) Dysentery
Levine, M. M., DuPont, H. L., Formal, S. B., Hornick, R. B., Takeuchi, A., Gangarosa, E. J., Snyder, M. J., & Libonati, J. P. (1973) · Journal of Infectious Diseases · doi:10.1093/infdis/127.3.261 · Cited by 246 · cited 1×
“For others, such as Shigella dysenteriae or enterotoxigenic Escherichia coli, administration with sodium bicarbonate buffer both reduces the inoculum dose required and results in a more consistent pattern of clinical infection [21–24].”
BackgroundEvaluation of a UDP-Glucose-4-Epimeraseless Mutant of Salmonella typhi as a Live Oral Vaccine
Gilman, R. H., Hornick, R. B., Woodward, W. E., DuPont, H. L., Snyder, M. J., Levine, M. M., & Libonati, J. P. (1977) · Journal of Infectious Diseases · doi:10.1093/infdis/136.6.717 · Cited by 217
Typhoid Fever: Pathogenesis and Immunologic Control
Hornick, R. B., Greisman, S. E., Woodward, T. E., DuPont, H. L., Hawkins, A. T., & Snyder, M. J. (1970) · New England Journal of Medicine · doi:10.1056/nejm197010012831406 · Cited by 184 · cited 1×
“In particular, lower levels of pathogen exposure are thought to more closely replicate natural infection and there is less chance of overwhelming any infection- or vaccinederived protective responses seen, an issue noted previously in typhoid challenge/vaccine studies [10, 22, 23, 25].”
BackgroundThe diagnostic significance of relative bradycardia in infectious disease
Cunha, B. A. (2000) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2000.0194f.x · Cited by 136 · cited 1×
“9°C (heart rate <120 bpm) [20].”
Research works printed but not linked: 3
- Standards Unit Investigation of blood cultures (for organisms other than Mycobacterium species) 2013 Vol. B37 UK Standards for Microbiological Investigations. London: Health Protection Agency
- Standards Unit Identification of Salmonella species 2011 Vol. ID 24 UK Standards for Microbiology Investigations. London: Health Protection Agency
- Woodard WE Summary of 1886 subjects in volunteer challenges 1980 Maryland University of Maryland, School of Medicine
Cited by
Items 101–148 of 148
Are placebo controls necessary in controlled human infection trials for vaccines?
Langenberg, M. C. C., Dekkers, O. M., & Roestenberg, M. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30020-7 · Cited by 8
Within-host mathematical modelling of the incubation period of Salmonella Typhi
Awofisayo-Okuyelu, A., Pratt, A. C., McCarthy, N. D., & Hall, I. (2019) · Royal Society Open Science · doi:10.1098/rsos.182143 · Cited by 9
“[41], we estimated the incubation period from our model output.”
BackgroundMethodUsing a Systems Biology Approach To Study Host-Pathogen Interactions
Yeung, A. T. Y., Hale, C. B., Clare, S., Palmer, S., Scott, J. B., Baker, S. G., & Dougan, G. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.bai-0021-2019 · Cited by 8
Rapaka, R. R., Wahid, R., Fresnay, S., Booth, J. S., Darton, T. C., Jones, C., Waddington, C. S., Levine, M. M., Pollard, A. J., & Sztein, M. B. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1178 · Cited by 9
“Participants and human challenge model Data were collected from clinical samples obtained from a human challenge model of typhoid fever (UKCRN ID 9297; approval: Oxfordshire Research Ethics Committee A [10/ H604/53], as previously described by Waddington et al.77 Male or female volunteers, healthy, between ages 18 and…”
MethodInfluentialSelf-citationTyphoid and paratyphoid fevers
Parry, C. M., & Basnyat, B. (2020) · doi:10.1093/med/9780198746690.003.0113 · Cited by 6
Williams, E., Low, S. J., Pollock, G. L., Taouk, M. L., Prestedge, J., Howden, B. P., Chow, E. P. F., Fairley, C. K., Seib, K. L., McCarthy, J. S., et al. (2025) · The Lancet Microbe · doi:10.1016/j.lanmic.2025.101105 · Cited by 5
Early transcriptional responses to human enteric fever challenge
Barton, A., Hill, J. W., O’Connor, D., Jones, C., Jones, E. A., Camara, S., Shrestha, S., Jin, C., Gibani, M. M., Dobinson, H., et al. (2023) · Infection and Immunity · doi:10.1128/iai.00108-23 · Cited by 3
“Whereas, the typhoid- (15) and paratyphoid-dose finding (16) studies aimed to find the inoculum dose that would give an attack rate of 60%–75%, the typhoid oral vaccine trial (7), typhoid parenteral vaccine trial (17), typhoid toxin study (18), and re-challenge study (19) aimed to find the effect of oral vaccination,…”
Self-citationREVIEW : PATOGENESIS DAN DIAGNOSA LABORATORIUM DEMAM TIFOID
Normaidah, N. (2020) · Klinikal Sains Jurnal Analis Kesehatan · doi:10.36341/klinikal_sains.v8i2.1409 · Cited by 5
Shigella-Controlled Human Infection Models: Current and Future Perspectives
Clarkson, K. A., Porter, C. K., Talaat, K. R., Kapulu, M. C., Chen, W. H., Frenck, R. W., Bourgeois, A. L., Kaminski, R. W., & Martin, L. B. (2021) · Current topics in microbiology and immunology · doi:10.1007/82_2021_248 · Cited by 6
Levine, M. M., Neuzil, K. M., & Pollard, S. A. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00062-1 · Cited by 5
Walker, J. W., Russell, P., Kermack, L. M., Van, T. T., Nga, T. V. T., Mylona, E., Camara, S., Kim, Y. C., Shrestha, S., Gehlhaar, A., et al. (2025) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0013612 · Cited by 8
“However, anti-Vi IgG is often not elevated following infection, and the use of this antigen as the basis for typhoid conjugate vaccines (TCV) will confound its use as a marker of recent infection following vaccine introduction [7,23,24].”
InfluentialWilliams, E., Pollock, G. L., Price, D. J., Crocker-Buqué, T., de Kretser, D., Jamrozik, E., Osowicki, J., Pasricha, S., Azzato, F., Steer, A. C., et al. (2025) · Wellcome Open Research · doi:10.12688/wellcomeopenres.25103.1 · Cited by 6
“Gastrointestinal bacterial CHIMs such as Salmonella enterica serovar Typhi 36 , Salmonella enterica serovar Paratyphi A 37 , and non-typhoidal Salmonella 39 are also informative in that each involve infection with a transmissible bacterial pathogen with a large and highly diverse genome, similar to…”
Booth, J. S., Rapaka, R. R., McArthur, M. A., Fresnay, S., Darton, T. C., Blohmke, C. J., Jones, C., Waddington, C. S., Levine, M. M., Pollard, A. J., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1384642 · Cited by 4
Self-citationToapanta, F. R., Hu, J., Shirey, K. A., Bernal, P. J., Levine, M. M., Darton, T. C., Waddington, C. S., Pollard, A. J., & Sztein, M. B. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1454857 · Cited by 5
Self-citationA Questionnaire-based Study Exploring Participant Perspectives in a Perinatal Human Challenge Trial
Bevan, J., Theodosiou, A. A., Corner, J., Dorey, R. B., Read, R. C., & Jones, C. E. (2023) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000004036 · Cited by 4
Sexually transmitted enteric infections in men who have sex with men
Newman, K. L., Newman, G. S., Cannon, C. A., & Fang, F. C. (2025) · Clinical Microbiology Reviews · doi:10.1128/cmr.00075-23 · Cited by 5
“The incubation period is 4–14 days, but can be longer, with bacteria often detectable in stool before the onset of symptoms (134).”
Severe Typhoid Fever Complicated by Superior Mesenteric and Splenic Vein Thrombosis
Veronese, P., Pappalardo, M., Maffini, V., Rubini, M., Giacometti, A., Ruozi, M. B., Cella, S., & Dodi, I. (2023) · Infectious Disease Reports · doi:10.3390/idr15040038 · Cited by 6
“On blood tests, most patients have a total white blood cell count that is within the normal range and leukocytosis may suggest intestinal perforation [23].”
BackgroundStockdale, L. K., de Haan, N., Hill, J. W., Johnson, M., Tomić, A., Wuhrer, M., Jones, E. A., Jin, C., Nouta, J., Koeleman, C. A. M., et al. (2022) · Frontiers in Analytical Science · doi:10.3389/frans.2022.1005558 · Cited by 4
“(Waddington et al., 2014), this finding is unsurprising but nonetheless an important observation, and the first such following a controlled human challenge.”
BackgroundAshton, P., Mageiros, L., Meiring, J., Chirambo, A. C., Khanam, F., Dongol, S., Banda, H., Karkey, A., Preciado‐Llanes, L., Thomaides-Brears, H. B., et al. (2025) · Microbiome · doi:10.1186/s40168-025-02125-7 · Cited by 4
Vicentine, M. P., McCann, N. S., Hennigan, O., Maria, N., Molina, C. I. J., Koleva, S., Islam, M. K., Jones, E., Flaxman, A. L., Day, N., et al. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-107608 · Cited by 3
“24 The Oxford Vaccine Group (OVG) has established a typhoid 42 and a paratyphoid CHIM.”
Using a Systems Biology Approach To Study Host-Pathogen Interactions
Yeung, A. T. Y., Hale, C. B., Clare, S., Palmer, S., Scott, J. B., Baker, S. G., & Dougan, G. (2020) · John Wiley & Sons, Inc. eBooks · doi:10.1128/9781683670261.ch24 · Cited by 2
Britto, C., Mathias, S., Bosco, A., Dyson, Z. A., Dougan, G., Raveendran, S., Abin, V. L., Jose, S., Nagaraj, S. V., Holt, K. E., et al. (2020) · Tropical Medicine and Health · doi:10.1186/s41182-020-00247-2 · Cited by 4
“1) to infect all participants, and the clinical as well laboratory features differed widely [8].”
BackgroundResultInduction of Local and Systemic Immunity by Salmonella Typhi in Humans
Toapanta, F. R., Booth, J. S., & Sztein, M. B. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-811924-2.00029-8 · Cited by 2
Diagnostic Value of Eosinopenia in Non-Typhi Salmonella Enteritis
Farmakiotis, D., Ntouloulis, C., Mihailidis, N., Theofilogiannakos, E. K., Makavos, G., Bakas, A., & Vassiliadou, E. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu557 · Cited by 2
Seshadri, C., Flynn, J. L., Maiello, P. A., Schnappinger, D., Wilkinson, R. J., Gordon, S. B., Mwandumba, H. C., Jambo, K., Hoft, D. F., Rubin, E. J., et al. (2026) · The Lancet Microbe · doi:10.1016/j.lanmic.2025.101278 · Cited by 1
“For example, Salmonella enterica serotype Typhi is delivered orally and causes bacteraemia; 9 Plasmodium falciparum is delivered via mosquito bites and causes clinical malaria.”
Arshad, S., Younas, S., Qadir, M. L., Hussain, N., Saleem, M., Ali, Q., Han, S., & Ali, D. (2026) · Scientific Reports · doi:10.1038/s41598-026-35011-9 · Cited by 2
Bennett, A. N., Cole, A. L., & Gunn, J. S. (2026) · Infection and Immunity · doi:10.1128/iai.00028-26 · Cited by 1
“Salmonella gains access to the systemic circulation by surviving phagocytic killing within SCVs and then is transported by these phagocytes through systemic circulation to the spleen, liver, and other lymphocytic organs (35–39).”
Liu, J., Liu, H., Wen, Q., Zhou, L., Li, Z., Peng, S., & Liu, W. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.151785 · Cited by 1
Kanwal, M., Waheed, F., Shahzadi, H., Shahbaz, M., & Noor, A. (2020) · THE JOURNAL OF MICROBIOLOGY AND MOLECULAR GENETICS · doi:10.52700/jmmg.v1i2.13 · Cited by 1
“In Oxford, UK, a controlled human infection model (CHIM) was created to quicken vaccine research, both with S. Typhi and S. Para typhi (Waddington et al., 2014).”
BackgroundTyphoid Fever and Other Enteric Fevers
Dolecek, C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-7020-6285-8.00115-5 · Cited by 2
Calle, I. R., Rial, J. G., Bont, L., Gessner, B. D., Kohn, M. A., Dagan, R., Payne, D. C., Bruni, L., Pollard, A. J., García‐Sastre, A., et al. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1788301 · Cited by 1
“However, these models seem to underestimate the effectiveness of the vaccine compared to field studies.(100) Among the new alternatives, conjugate vaccines (TCVs) have demonstrated promising results in terms of efficacy and bacterial load reduction in human challenge models,(101) showing correlation between protection…”
ResultSazzad, J., Alam, M. S., Das, H. S., Rahman, N., Haque, Q. T., & Rahman, K. M. (2023) · TAJ Journal of Teachers Association · doi:10.3329/taj.v35i2.63737 · Cited by 1
Editorial: How Salmonella Infection can Inform on Mechanisms of Immune Function and Homeostasis
López-Macías, C. I. R., & Cunningham, A. F. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00451 · Cited by 1
“is the reintroduction of the human challenge model for typhoid (17, 18).”
BackgroundDiagnosis of acute and chronic enteric fever using metabolomics
Näsström, E. (2017) · DiVA at Umeå University (Umeå University) · Cited by 3
Waddington, C. S., Darton, T. C., Angus, B., & Pollard, A. J. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu561
“TO THE EDITOR—Our recent development of a human Salmonella Typhi challenge model provided a detailed description of the clinical profile and associated pathological changes seen during typhoid fever [1].”
Self-citationCunningham, A. F. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.13009-7
Human induced pluripotent stem cells for modeling of Salmonella infection
Forbester, J. L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823808-0.00009-2
Horii, T., & Palacpac, N. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734512379.793555663
Wiersinga, W. J., & Haak, B. W. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736520413.793564864
SALMONELLA DISEASE WITH A HEALTH MANAGEMENT PERSPECTIVE
Demiray, E. K. D., & Sayar, B. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1005026 · Cited by 1
Moshe, N. B. B., Hen‐Avivi, S., Levy-Efrati, L., Veinman, L., Hill, J. W., O’Connor, D., Verheul, M. K., Stockdale, L. K., McLean, F. E., Pollard, A. J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.08.631852
Smith, C., Bzami, A., Zhu, X., White, J. A., Roa, N., Suvarnapunya, A. E., Smith, E., Rýdlová, A., Varro, R., Kiliddar, Z., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.24.650425 · Cited by 1
“A sodium bicarbonate dose of 0.26g (representing a 2.6g human dose) was evaluated and represents the formulation used in previous Salmonella Typhi and Paratyphi challenge models [24].”
InfluentialCunningham, A. F. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00204-0
(2025) · Elsevier eBooks · doi:10.1016/b978-3-437-21642-8.00003-0
Britto, C., Mathias, S., Bosco, A., Dyson, Z. A., Dougan, G., Raveendran, S., Abin, V. L., Jose, S., Nagaraj, S., Holt, K. E., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12645623
Expert Consensus on Controlled Human Infection Studies for Gonorrhea
Hodgson, S. H. C., McCarthy, J. S., Duncan, J. A., Williams, E., McLaughlin, S. E., Alaimo, C., Davis, P., Delany, I., Douglas, A. D., Gray‐Owen, S. D., et al. (2026) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiag486
Booth, J. S., Rapaka, R. R., McArthur, M. A., Fresnay, S., Darton, T. C., Guo, B., Waddington, C. S., Levine, M. M., Pollard, A. J., & Sztein, M. B. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1924754
“…Levine et al., 1999; Salerno-Goncalves et al., 2002; Salerno-Goncalves et al., 2004; Salerno-Goncalves et al., 2005; Salerno-Goncalves et al., 2010; Waddington et al., 2014; Klemm et al., 2018; Shakya et al., 2019; Jamilah et al., 2020; Patel et al., 2021; Qadri et al., 2021; Shakya et al., 2021;…”
InfluentialSelf-citationGastrointestinal Bacterial Pathogens
Simon, R., & Levine, M. M. (2026) · Springer eBooks · doi:10.1007/978-3-032-37993-1_15
Metadata
- Authors
- Waddington, C. S., Darton, T. C., Jones, C., Haworth, K., Peters, A., John, T., Thompson, B. A. V., Kerridge, S. A., Kingsley, R. A., Zhou, L., Holt, K. E., Yu, L.-M., Lockhart, S., Farrar, J. J., Sztein, M. B., Dougan, G., Angus, B., Levine, M. M., & Pollard, A. J.
- Affiliations
- University of Oxford (GB)
- National Institute for Health and Care Research (GB)
- Wellcome Sanger Institute (GB)
- The University of Melbourne (AU)
- Emergent BioSolutions (United Kingdom) (GB)
- University of Maryland, Baltimore (US)
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-02-10
- Volume
- 58
- Issue
- 9
- Pages
- 1230-1240
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC3982839
- OpenAlex
- W2123106908
- Cited by
- 148
- References
- 37
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 3 · 2023: 9 · 2022: 9 · 2021: 8 · 2020: 16 · 2019: 15 · 2018: 11 · 2017: 23 · 2016: 12 · 2015: 14 · 2014: 7
- FWCI
- 26.72
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by
- Locations
- Clinical Infectious Diseases (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- UWA Profiles and Research Repository (UWA) (publishedVersion, other-oa)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Funders
- Wellcome Trust (100891, 092661)
- National Institute for Health and Care Research (ACF-2007-12-003)
- University of Oxford
- National Institutes of Health
- Centers for Disease Control and Prevention
- NIHR Oxford Biomedical Research Centre
- National Institute of Allergy and Infectious Diseases (R01AI036525, U19AI082655)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Salmonella and Campylobacter epidemiology
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Life Sciences › Immunology and Microbiology › Microbiology › Vibrio bacteria research studies
- Keywords
- typhoid fever, Salmonella typhi, human challenge model, controlled human infection model, sodium bicarbonate solution, dose escalation, attack rate, fecal shedding, lipopolysaccharide antigen, Vi antibody
- MeSH terms
- Adolescent, Adult, Ambulatory Care, Antibodies, Bacterial, Female, Humans, Male, Middle Aged, Salmonella typhi, Typhoid Fever, Typhoid-Paratyphoid Vaccines, Bacteremia, Sodium Bicarbonate, Models, Immunological, Host-Pathogen Interactions, Bacterial Shedding
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.